Evkeeza® (evinacumab-dgnb)
| Full Name | Evkeeza® (evinacumab-dgnb) |
| Drug | Evkeeza |
| Manufacturer | Regeneron Pharmaceuticals |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Adjunct to other low-density lipoprotein-cholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 12 years and older, with homozygous familial hypercholesterolemia (HoFH) |
| Disease | Homozygous Familial Hypercholesterolemia (HoFH) |
| Therapeutic Area | Cardiology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 800-645-4142 |
| Fax Number | 877-473-0199 |
| Product Website | evkeezahcp.com |